DICE Therapeutics Inc (DICE) Fundamental Analysis & Valuation

NASDAQ:DICE • US23345J1043

Current stock price

47.55 USD
+0.03 (+0.06%)
At close:
47.59 USD
+0.04 (+0.08%)
After Hours:

This DICE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DICE Profitability Analysis

1.1 Basic Checks

  • In the past year DICE has reported negative net income.
  • In the past year DICE has reported a negative cash flow from operations.
DICE Yearly Net Income VS EBIT VS OCF VS FCFDICE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -20M -40M -60M -80M

1.2 Ratios

  • DICE has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DICE Yearly ROA, ROE, ROICDICE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -10 -20 -30 -40

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DICE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DICE Yearly Profit, Operating, Gross MarginsDICE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. DICE Health Analysis

2.1 Basic Checks

  • DICE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DICE has been increased compared to 1 year ago.
  • There is no outstanding debt for DICE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DICE Yearly Shares OutstandingDICE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M
DICE Yearly Total Debt VS Total AssetsDICE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • DICE has an Altman-Z score of 47.54. This indicates that DICE is financially healthy and has little risk of bankruptcy at the moment.
  • DICE's Altman-Z score of 47.54 is amongst the best of the industry. DICE outperforms 98.10% of its industry peers.
  • There is no outstanding debt for DICE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 47.54
ROIC/WACCN/A
WACC8.94%
DICE Yearly LT Debt VS Equity VS FCFDICE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 200M 400M

2.3 Liquidity

  • DICE has a Current Ratio of 32.44. This indicates that DICE is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 32.44, DICE belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
  • A Quick Ratio of 32.44 indicates that DICE has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 32.44, DICE belongs to the best of the industry, outperforming 97.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 32.44
Quick Ratio 32.44
DICE Yearly Current Assets VS Current LiabilitesDICE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. DICE Growth Analysis

3.1 Past

  • The earnings per share for DICE have decreased strongly by -20.98% in the last year.
  • The Revenue for DICE has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-20.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, DICE will show a very negative growth in Earnings Per Share. The EPS will decrease by -14.28% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-22.45%
EPS Next 2Y-26.68%
EPS Next 3Y-23.74%
EPS Next 5Y-14.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DICE Yearly Revenue VS EstimatesDICE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2025 2026 2027 2028 2029 2030 200M 400M 600M
DICE Yearly EPS VS EstimatesDICE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6

More info and screens

Find the best growth stocksShow best growing peers

0

4. DICE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DICE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DICE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DICE Price Earnings VS Forward Price EarningsDICE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DICE Per share dataDICE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • DICE's earnings are expected to decrease with -23.74% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.68%
EPS Next 3Y-23.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DICE Dividend Analysis

5.1 Amount

  • No dividends for DICE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

DICE Fundamentals: All Metrics, Ratios and Statistics

DICE Therapeutics Inc

NASDAQ:DICE (8/8/2023, 9:37:47 PM)

After market: 47.59 +0.04 (+0.08%)

47.55

+0.03 (+0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-10
Earnings (Next)N/A
Inst Owners0.04%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.27B
Revenue(TTM)N/A
Net Income(TTM)-90.94M
Analysts52.86
Price Target50.36 (5.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.31%
Min EPS beat(2)-2.95%
Max EPS beat(2)9.57%
EPS beat(4)2
Avg EPS beat(4)3.48%
Min EPS beat(4)-2.95%
Max EPS beat(4)9.75%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.31%
PT rev (3m)-20.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.58%
EPS NY rev (1m)2.5%
EPS NY rev (3m)2.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.16
P/tB 4.16
EV/EBITDA N/A
EPS(TTM)-2.18
EYN/A
EPS(NY)-3.43
Fwd EYN/A
FCF(TTM)-1.56
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS0
BVpS11.44
TBVpS11.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 223.75%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 32.44
Quick Ratio 32.44
Altman-Z 47.54
F-Score3
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)133.67%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
EPS Next Y-22.45%
EPS Next 2Y-26.68%
EPS Next 3Y-23.74%
EPS Next 5Y-14.28%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-58.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.7%
OCF growth 3YN/A
OCF growth 5YN/A

DICE Therapeutics Inc / DICE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DICE Therapeutics Inc?

ChartMill assigns a fundamental rating of 2 / 10 to DICE.


What is the valuation status for DICE stock?

ChartMill assigns a valuation rating of 0 / 10 to DICE Therapeutics Inc (DICE). This can be considered as Overvalued.


How profitable is DICE Therapeutics Inc (DICE) stock?

DICE Therapeutics Inc (DICE) has a profitability rating of 0 / 10.


Can you provide the financial health for DICE stock?

The financial health rating of DICE Therapeutics Inc (DICE) is 8 / 10.


What is the earnings growth outlook for DICE Therapeutics Inc?

The Earnings per Share (EPS) of DICE Therapeutics Inc (DICE) is expected to decline by -22.45% in the next year.